Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Superior Uniform Group Inc
Superior Group of Companies Reports Third Quarter 2025 Results
Business
Nov 3 2025
11 min read

Superior Group of Companies Reports Third Quarter 2025 Results

news images


– Total net sales of $138.5 million, compared to $149.7 million in prior year third quarter

– Net income of $2.7 million, compared to $5.4 million in prior year third quarter 

– EBITDA of $7.5 million, compared to $11.7 million in prior year third quarter

– Board of Directors approves $0.14 per share quarterly dividend –

 

ST. PETERSBURG, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its third quarter 2025 results.

“Our earnings were as expected, demonstrating solid sequential progress from the second quarter and our updated full-year outlook reflects a higher mid-point,” said Michael Benstock, Chief Executive Officer. “We were also able to meaningfully improve SG&A, which bodes well for future profitability as greater economic clarity emerges. For now, our enhanced selling capabilities and competitive advantages continue to drive growth in our business pipelines, even during this period of volatile trade policy and uncertainty for customers and prospects. We are leveraging our diverse supply base and offering alternative products and solutions, while also benefiting from our own diversity across business segments and the end markets we serve. With our strong balance sheet, we can invest for future growth while paying an attractive dividend as we work to create long-term shareholder value.”

Third Quarter Results

For the third quarter ended September 30, 2025, net sales were $138.5 million, compared to third quarter 2024 net sales of $149.7 million. Pretax earnings of $3.2 million compared to $6.6 million in the third quarter of 2024. Net earnings of $2.7 million or $0.18 per diluted share compared to net income of $5.4 million or $0.33 per diluted share for the third quarter of 2024.

Third Quarter 2025 Dividend

The Board of Directors declared a quarterly dividend of $0.14 per share, payable November 28, 2025 to shareholders of record as of November 14, 2025.

2025 Full-Year Outlook

The Company is updating its full-year revenue outlook range from $550 million to $575 million to $560 million to $570 million.

Webcast and Conference Call

The Company will host a webcast and conference call at 5:00 pm Eastern Time today. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/Presentations. Interested individuals may also join the teleconference by dialing 1-844-861-5505 for U.S. dialers and 1-412-317-6586 for International dialers. The Canadian toll-free number is 1-866-605-3852. Please ask to be joined to the Superior Group of Companies call. A telephone replay of the teleconference will be available through November 17, 2025. To access the replay, dial 1-877-344-7529 in the United States or 1-412-317-0088 from international locations. Canadian dialers can access the replay at 855-669-9658. Please reference conference number 6514610 for replay access.

Disclosure Regarding Forward Looking Statements

Certain matters discussed in this press release are forward-looking statements intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “project,” “potential, or plan or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release may include, without limitation: (1) projections of revenue, income, and other items relating to our financial position and results of operations, including short term and long term plans for cash, (2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations and (4) statements of expected industry and general economic trends.

Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; the effect of existing and/or new or expanded tariffs, uncertainties related to supply disruptions, inflationary environment (including with respect to the cost of finished goods and raw materials and shipping costs), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of the United States of America (U.S. or United States) in which the Companys customers are located; changes in the healthcare, retail chain, food service, transportation and other industries where uniforms and service apparel are worn; our ability to identify suitable acquisition targets, discover liabilities associated with such businesses during the diligence process, successfully integrate any acquired businesses, or successfully manage our expanding operations; the price and availability of raw materials; attracting and retaining senior management and key personnel; the effect of the Companys previously disclosed material weakness in internal control over financial reporting; the Company may identify a material weakness in internal control in the future, which could result in us not preventing or detecting on a timely basis a material misstatement of the Companys financial statements and to maintain effective internal control over financial reporting; and other factors described in the Companys filings with the Securities and Exchange Commission, including those described in the Risk Factors section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

About Superior Group of Companies, Inc. (SGC):

Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com.

Investor Relations Contact:
Investors@Superiorgroupofcompanies.com

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except shares and per share data)

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Net sales

 

$

138,467

 

 

$

149,690

 

 

$

419,609

 

 

$

420,268

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

 

85,389

 

 

 

89,144

 

 

 

260,764

 

 

 

253,650

 

Selling and administrative expenses

 

 

48,513

 

 

 

52,404

 

 

 

150,855

 

 

 

149,906

 

Interest expense, net

 

 

1,378

 

 

 

1,569

 

 

 

3,873

 

 

 

4,897

 

 

 

 

135,280

 

 

 

143,117

 

 

 

415,492

 

 

 

408,453

 

Income before income tax expense

 

 

3,187

 

 

 

6,573

 

 

 

4,117

 

 

 

11,815

 

Income tax expense

 

 

443

 

 

 

1,170

 

 

 

580

 

 

 

1,900

 

Net income

 

$

2,744

 

 

$

5,403

 

 

$

3,537

 

 

$

9,915

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.19

 

 

$

0.34

 

 

$

0.24

 

 

$

0.62

 

Diluted

 

$

0.18

 

 

$

0.33

 

 

$

0.23

 

 

$

0.60

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding during the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

14,738,863

 

 

 

16,107,549

 

 

 

15,050,834

 

 

 

16,118,885

 

Diluted

 

 

15,119,050

 

 

 

16,543,990

 

 

 

15,422,144

 

 

 

16,588,914

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash dividends per common share

 

$

0.14

 

 

$

0.14

 

 

$

0.42

 

 

$

0.42

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except shares and par value data)

 

 

 

 

 

 

 

 

 

September 30,

 

 

December 31,

 

 

 

2025

 

 

2024

 

 

 

(Unaudited)

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

16,651

 

 

$

18,766

 

Accounts receivable, net

 

 

97,415

 

 

 

95,092

 

Inventories

 

 

105,655

 

 

 

96,675

 

Contract assets

 

 

48,623

 

 

 

51,688

 

Prepaid expenses and other current assets

 

 

11,685

 

 

 

10,831

 

Total current assets

 

 

280,029

 

 

 

273,052

 

Property, plant and equipment, net

 

 

38,830

 

 

 

41,879

 

Operating lease right-of-use assets

 

 

12,726

 

 

 

15,567

 

Deferred tax asset

 

 

13,828

 

 

 

13,835

 

Intangible assets, net

 

 

48,440

 

 

 

51,137

 

Goodwill

 

 

2,434

 

 

 

2,304

 

Other assets

 

 

18,985

 

 

 

17,360

 

Total assets

 

$

415,272

 

 

$

415,134

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

45,727

 

 

$

50,942

 

Other current liabilities

 

 

42,902

 

 

 

44,367

 

Current portion of long-term debt

 

 

6,094

 

 

 

5,625

 

Current portion of acquisition-related contingent liabilities

 

 

648

 

 

 

814

 

Total current liabilities

 

 

95,371

 

 

 

101,748

 

Long-term debt

 

 

93,906

 

 

 

80,410

 

Long-term pension liability

 

 

13,614

 

 

 

13,315

 

Long-term acquisition-related contingent liabilities

 

 

743

 

 

 

935

 

Long-term operating lease liabilities

 

 

7,875

 

 

 

10,486

 

Other long-term liabilities

 

 

9,927

 

 

 

9,384

 

Total liabilities

 

 

221,436

 

 

 

216,278

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock, $.001 par value - authorized 300,000 shares (none issued)

 

 

-

 

 

 

-

 

Common stock, $.001 par value - authorized 50,000,000 shares, issued and outstanding 15,968,792 and 16,484,921 shares, respectively

 

 

15

 

 

 

16

 

Additional paid-in capital

 

 

84,541

 

 

 

84,060

 

Retained earnings

 

 

112,561

 

 

 

120,139

 

Accumulated other comprehensive loss, net of tax:

 

 

(3,281

)

 

 

(5,359

)

Total shareholders’ equity

 

 

193,836

 

 

 

198,856

 

Total liabilities and shareholders’ equity

 

$

415,272

 

 

$

415,134

 

 

 

 

 

 

 

 

 

 


 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

 

 

 

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

 

Net income

 

$

3,537

 

 

$

9,915

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

9,157

 

 

 

9,872

 

Inventory write-downs

 

 

1,793

 

 

 

1,893

 

Credit loss expense

 

 

2,347

 

 

 

251

 

Share-based compensation expense

 

 

3,916

 

 

 

2,905

 

Change in fair value of acquisition-related contingent liabilities

 

 

659

 

 

 

363

 

Non-cash operating lease expense

 

 

2,843

 

 

 

1,625

 

Other, net

 

 

244

 

 

 

653

 

Changes in assets and liabilities, net of acquisition of a business:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(3,710

)

 

 

3,891

 

Contract assets

 

 

3,326

 

 

 

(1,671

)

Inventories

 

 

(10,535

)

 

 

2,241

 

Prepaid expenses and other current assets

 

 

(423

)

 

 

(1,292

)

Other assets

 

 

(1,692

)

 

 

(959

)

Accounts payable and other current liabilities

 

 

(10,636

)

 

 

(5,917

)

Payment of acquisition-related contingent liabilities

 

 

(791

)

 

 

(686

)

Other long-term liabilities

 

 

1,235

 

 

 

1,413

 

Net cash provided by operating activities

 

 

1,270

 

 

 

24,497

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Additions to property, plant and equipment

 

 

(3,407

)

 

 

(2,911

)

Net cash used in investing activities

 

 

(3,407

)

 

 

(2,911

)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Borrowings under revolving lines of credit

 

 

76,000

 

 

 

31,000

 

Payments under revolving lines of credit

 

 

(58,000

)

 

 

(37,000

)

Payments of term loan

 

 

(4,218

)

 

 

(3,281

)

Payment of cash dividends

 

 

(6,713

)

 

 

(6,994

)

Payment of acquisition-related contingent liabilities

 

 

(226

)

 

 

(897

)

Proceeds received on exercise of stock options and payments for shares withheld for taxes

 

 

90

 

 

 

1,118

 

Common shares repurchased and retired

 

 

(7,928

)

 

 

(6,346

)

Net cash used in financing activities

 

 

(995

)

 

 

(22,400

)

 

 

 

 

 

 

 

 

 

Effect of currency exchange rates on cash

 

 

1,017

 

 

 

(709

)

Net decreases in cash and cash equivalents

 

 

(2,115

)

 

 

(1,523

)

Cash and cash equivalents balance, beginning of period

 

 

18,766

 

 

 

19,896

 

Cash and cash equivalents balance, end of period

 

$

16,651

 

 

$

18,373

 

 

 

 

 

 

 

 

 

 


 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

NON-GAAP FINANCIAL MEASURES

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Net income

 

$

2,744

 

 

$

5,403

 

 

$

3,537

 

 

$

9,915

 

Interest expense, net

 

 

1,378

 

 

 

1,569

 

 

 

3,873

 

 

 

4,897

 

Income tax expense

 

 

443

 

 

 

1,170

 

 

 

580

 

 

 

1,900

 

Depreciation and amortization

 

 

2,975

 

 

 

3,252

 

 

 

9,157

 

 

 

9,872

 

Impairment charge

 

 

-

 

 

 

260

 

 

 

-

 

 

 

260

 

EBITDA(1)

 

$

7,540

 

 

$

11,654

 

 

$

17,147

 

 

$

26,844

 

EBITDA margin(1)

 

 

5.4

%

 

 

7.8

%

 

 

4.1

%

 

 

6.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) EBITDA, which is a non-GAAP financial measure, is defined as net income excluding interest expense, net, income tax expense and depreciation and amortization expense. EBITDA margin is defined as EBITDA divided by net sales. The Company believes EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Company’s core operating results from period to period by removing (i) the impact of the Company’s capital structure (interest expense from outstanding debt), (ii) tax consequences and (iii) asset base (depreciation and amortization). The Company uses EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. EBITDA is not a measure of financial performance under GAAP.  EBITDA should not be considered in isolation or as an alternative to net income, cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate EBITDA are significant components in understanding and assessing the Company’s results of operations. The Company’s EBITDA may not be comparable to a similarly titled measure of another company because other entities may not calculate EBITDA in the same manner.

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

SUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Branded Products

 

 

Healthcare Apparel

 

 

Contact Centers

 

 

Intersegment Eliminations

 

 

Other

 

 

Total

 

For the Three Months Ended September 30, 2025:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

85,095

 

 

$

31,520

 

 

$

22,664

 

 

$

(812

)

 

$

-

 

 

$

138,467

 

Cost of goods sold

 

 

55,466

 

 

 

19,394

 

 

 

10,669

 

 

 

(140

)

 

 

-

 

 

 

85,389

 

Gross margin

 

 

29,629

 

 

 

12,126

 

 

 

11,995

 

 

 

(672

)

 

 

-

 

 

 

53,078

 

Selling and administrative expenses

 

 

23,501

 

 

 

9,779

 

 

 

10,283

 

 

 

(672

)

 

 

5,622

 

 

 

48,513

 

Depreciation and amortization

 

 

1,396

 

 

 

832

 

 

 

661

 

 

 

-

 

 

 

86

 

 

 

2,975

 

Segment EBITDA(1)

 

$

7,524

 

 

$

3,179

 

 

$

2,373

 

 

$

-

 

 

$

(5,536

)

 

$

7,540

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Branded Products

 

 

Healthcare Apparel

 

 

Contact Centers

 

 

Intersegment Eliminations

 

 

Other

 

 

Total

 

For the Three Months Ended September 30, 2024:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

92,547

 

 

$

33,025

 

 

$

25,038

 

 

$

(920

)

 

$

-

 

 

$

149,690

 

Cost of goods sold

 

 

59,037

 

 

 

19,216

 

 

 

11,296

 

 

 

(405

)

 

 

-

 

 

 

89,144

 

Gross margin

 

 

33,510

 

 

 

13,809

 

 

 

13,742

 

 

 

(515

)

 

 

-

 

 

 

60,546

 

Selling and administrative expenses

 

 

24,223

 

 

 

11,240

 

 

 

11,482

 

 

 

(515

)

 

 

5,974

 

 

 

52,404

 

Impairment charge

 

 

-

 

 

 

260

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

260

 

Depreciation and amortization

 

 

1,446

 

 

 

944

 

 

 

770

 

 

 

-

 

 

 

92

 

 

 

3,252

 

Segment EBITDA(1)

 

$

10,733

 

 

$

3,773

 

 

$

3,030

 

 

$

-

 

 

$

(5,882

)

 

$

11,654

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Branded Products

 

 

Healthcare Apparel

 

 

Contact Centers

 

 

Intersegment Eliminations

 

 

Other

 

 

Total

 

For the Nine Months Ended September 30, 2025:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

264,216

 

 

$

87,036

 

 

$

70,866

 

 

$

(2,509

)

 

$

-

 

 

$

419,609

 

Cost of goods sold

 

 

173,884

 

 

 

54,761

 

 

 

33,277

 

 

 

(1,158

)

 

 

-

 

 

 

260,764

 

Gross margin

 

 

90,332

 

 

 

32,275

 

 

 

37,589

 

 

 

(1,351

)

 

 

-

 

 

 

158,845

 

Selling and administrative expenses

 

 

72,353

 

 

 

29,383

 

 

 

32,816

 

 

 

(1,351

)

 

 

17,654

 

 

 

150,855

 

Depreciation and amortization

 

 

4,271

 

 

 

2,598

 

 

 

2,022

 

 

 

-

 

 

 

266

 

 

 

9,157

 

Segment EBITDA(1)

 

$

22,250

 

 

$

5,490

 

 

$

6,795

 

 

$

-

 

 

$

(17,388

)

 

$

17,147

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Branded Products

 

 

Healthcare Apparel

 

 

Contact Centers

 

 

Intersegment Eliminations

 

 

Other

 

 

Total

 

For the Nine Months Ended September 30, 2024:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

260,911

 

 

$

88,854

 

 

$

73,422

 

 

$

(2,919

)

 

$

-

 

 

$

420,268

 

Cost of goods sold

 

 

167,534

 

 

 

53,335

 

 

 

34,075

 

 

 

(1,294

)

 

 

-

 

 

 

253,650

 

Gross margin

 

 

93,377

 

 

 

35,519

 

 

 

39,347

 

 

 

(1,625

)

 

 

-

 

 

 

166,618

 

Selling and administrative expenses

 

 

70,486

 

 

 

30,931

 

 

 

32,436

 

 

 

(1,625

)

 

 

17,678

 

 

 

149,906

 

Impairment charge

 

 

-

 

 

 

260

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

260

 

Depreciation and amortization

 

 

4,513

 

 

 

2,837

 

 

 

2,246

 

 

 

-

 

 

 

276

 

 

 

9,872

 

Segment EBITDA(1)

 

$

27,404

 

 

$

7,685

 

 

$

9,157

 

 

$

-

 

 

$

(17,402

)

 

$

26,844

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Segment EBITDA is our primary measure of segment profitability under U.S. GAAP ASC 280 “Segment Reporting”. Amounts included in income before income tax expense and excluded from Segment EBITDA include: interest expense, net and depreciation and amortization expense. Total EBITDA is a non-GAAP financial measure. Please see reconciliation of Total EBITDA included in the Non-GAAP Financial Measures table above.